Facile preparation of N-doped corncob-derived carbon nanofiber efficiently encapsulating Fe2O3 nanocrystals towards high ORR electrocatalytic activity

Facile preparation of cost-effective and durable porous carbon-supported non-precious-metal/nitrogen electrocatalysts for oxygen reduction reaction(ORR)is extremely important for promoting the commercialized applications of such catalysts.In this work,the FeCl3-containing porphyrinato iron-based covalent porous polymer(FeCl3·FeP or-CPP)was fabricated in-situ onto porous corncob biomass supports via a simple one-pot method.Subsequent thermal-reduction pyrolysis at 700℃-900℃with CO2 gas as an activating agent resulted in Fe2O3-decorated and N-doped graphitic carbon composite Fe2O3@NC&bio-C with a high degree of graphitization of Fe-involved promotion during pyrolysis(Fe2O3=FeCl3·FePor-CPP derived Fe2O3;NC=N-doped graphene analog;bio-C=the corncob-derived hierarchically porous graphitic biomass carbon framework).The derivedα-Fe2O3 andγ-Fe2O3 nanocrystals(5-10 nm particle diameter)were all immobilized on the N-doped bio-C micro/nanofibers.Notably,the Fe2O3@NC&bio-C obtained at the pyrolysis temperature of 800℃(Fe2O3@NC&bio-C-800),exhibited unusual ORR catalytic efficiency via a 4-electron pathway with the onset and half-wave potentials of 0.96 V and 0.85 V vs.RHE,respectively.In addition,Fe2O3@NC&bio-C-800 also exhibited a high and stable limiting current density of-6.0 mA cm-2,remarkably stability(larger than 91%retention after 10000 s),and good methanol tolerance.The present work represents one of the best results for iron-based biomass material ORR catalysts reported to date.The high ORR activity is attributed to the uniformly distributedα-Fe2O3 andγ-Fe2O3 nanoparticles on the N-enriched carbon matrix with a large specific surface area of 772.6 m^2 g^-1.This facilitates favor faster electron movement and better adsorption of oxygen molecules on the surface of the catalyst.Nevertheless,comparative studies on the structure and ORR catalytic activity of Fe2O3@NC&bioC-800 with Fe2O3@bio-C-800 and NC&bio-C-800 clearly highlight the synergistic effect of the coexisting Fe2O3 nanocrystals,NC,and bio-C on the ORR performance.

Sodium dodecyl sulfate-decorated MOF-derived porous Fe2O3 nanoparticles: High performance, recyclable photocatalysts for fuel denitrification

Magnetically recyclable porous sodium dodecyl sulfate(SDS)/Fe2O3 hybrids,which combine the porous structure of Fe2O3 and hydrophobicity of SDS,have been successfully synthesized for the first time.Porous Fe2O3 has been first pyrolyzed from MIL-100(Fe)using a simple two-step calcination route.Then,the obtained porous Fe2O3 nanoparticles have been self-assembled with SDS molecules and yielded hydrophobic SDS/Fe2O3 hybrids.The porous SDS/Fe2O3 hybrids have been demonstrated to be highly efficient for the denitrification of pyridine under visible light irradiation.The pyridine removal ratio has reached values as high as 100%after irradiation for 240 min.Combining the results of a series of experimental measurements,it was concluded that the superior photocatalytic performance of SDS/Fe2O3 hybrids could be attributed to(i)the fast electron transport owing to the unique porous structure of Fe2O3,(ii)the superior visible light absorption of Fe2O3 nanoparticles,and(iii)the“bridge molecule”role of SDS efficiently improving the separation and transfer across the interfacial domain of SDS/Fe2O3 of photogenerated electron-hole pairs.More significantly,after the catalytic reaction,the SDS/Fe2O3 hybrids could be easily recovered using magnets and reused during subsequent cycles,which indicated their stability and recyclability.

Ultrafast Quasiparticle Dynamics and Electron-Phonon Coupling in(Li0.84Fe0.16)OHFe0.98Se

Distinctive superconducting behaviors between bulk and monolayer FeSe make it challenging to obtain a unified picture of all FeSe-based superconductors.We investigate the ultrafast quasiparticle(QP)dynamics of an intercalated superconductor(Li1-xFex)OHFe1-ySe,which is a bulk crystal but shares a similar electronic structure with single-layer FeSe on SrTiO3.We obtain the electron-phonon coupling(EPC)constant(0.22±0.04),which well bridges that of bulk FeSe crystal and single-layer FeSe on SrTiO3.Significantly,we find that such a positive correlation betweenλA1 g and superconducting Tc holds among all known FeSe-based superconductors,even in line with reported FeAs-based superconductors.Our observation indicates possible universal role of EPC in the superconductivity of all known categories of iron-based superconductors,which is a critical step towards achieving a unified superconducting mechanism for all iron-based superconductors.

High-Pressure Ultrafast Dynamics in Sr2Ir04:Pressure-Induced Phonon Bottleneck Effect

By integrating pump-probe ultrafast spectroscopy with diamond anvil cell(DAC)technique,we demonstrate a time-resolved ultrafast dynamics study on non-equilibrium quasiparticle(QP)states in.SVo/rQi under high pressure.On-site in situ condition is realized,where both the sample and DAC have fixed position during the experiment.The QP dynamics exhibits a salient pressure-induced phonon bottleneck feature at 20GPa,which corresponds to a gap shrinkage in the electronic structure.A structural transition is also observed at 32 GPa.In addition,the slowest relaxation component reveals possible heat diffusion or pressure-controlled local spin fluctuation associated with the gap shrinkage.Our work enables precise pressure dependence investigations of ultrafast dynamics,paving the way for reliable studies of high-pressure excited state physics.

延长腺相关病毒递送药物的半衰期提高治疗效果

延长基于蛋白质治疗药物的半衰期可以提高药物疗效。然而,基因治疗本质上是长期表达所需的治疗性药物,药物半衰期对基因治疗疗效的影响尚不清楚。在这项腺相关病毒(adeno-associated virus,AAV)基因治疗研究中,通过与免疫球蛋白G1(immunoglobulin G 1,IgG1)可溶性单体Fc区(soluble monomeric IgG1 fragment crystallizable,sFc)或Fc区融合,设计了几种能够延长半衰期的蛋白质。研究表明,延长AAV递送的小分子双功能蛋白和成纤维细胞生长因子21(fibroblast growth factor 21,FGF21)的半衰期显著增加了它们在血液循环中的浓度。此外,AAV递送FGF21延长其半衰期使2型糖尿病动物模型中肝损伤和血糖显著降低,并改善了葡萄糖耐量和胰岛素敏感性。这些结果证明了延长药物半衰期的基因治疗在应对人类疾病中的治疗潜力。

Single-domain antibodies as therapeutics for solid tumor treatment

Single-domain antibodies(sdAbs),initially identified in camelids or sharks and commonly referred to as nanobodies or VNARs,have emerged as a promising alternative to conventional therapeutic antibodies.These sdAbs have many superior physicochemical and pharmacological properties,including small size,good solubility and thermostability,easier accessible epitopes,and strong tissue penetration.However,the inherent challenges associated with the animal origin of sdAbs limit their clinical use.In recent years,various innovative humanization technologies,including complementarity-determining region(CDR)grafting or complete engineering of fully human sdAbs,have been developed to mitigate potential immunogenicity issues and enhance their compatibility.This review provides a comprehensive exploration of sdAbs,emphasizing their distinctive features and the progress in humanization methodologies.In addition,we provide an overview of the recent progress in developing drugs and therapeutic strategies based on sdAbs and their potential in solid tumor treatment,such as sdAbedrug conjugates,multispecific sdAbs,sdAb-based delivery systems,and sdAb-based cell therapy.

2022年中国双翅目新分类单元

本文总结了2022年国内外学者发表的中国双翅目新分类单元的情况。经统计,2022年共发表中国双翅目物种相关的论文75篇,涉及新分类单元176个,包括新属3个,新种173个;增加了中国新记录亚科2个,新记录属8个,新记录亚属1个,新记录种35个;提出了更名1个,异名变动10个。在2022年发表的所有中国双翅目新种中,舞虻科、寄蝇科、摇蚊科、果蝇科和蚤蝇科的数量最多,占全年发表新种总数的46%。新分类单元和新记录涉及27个省级行政区,云南发表的新种数明显高于其他地区,占全国新种发表总数的1/3;而北方地区的新记录种数高于南方。

Gene expression signatures for phlegm-dampness constitution of Chinese Medicine

Dear Editor, The term ＂individualized medicine＂ was first used in Bio- chemistry Individuality in 1956 by Williams （Williams et al., 1956）. With the emergence of the post-genome era in the 21 st century, individualized precision medicine has attracted increasing attention. In traditional Chinese medicine （TCM）, there is also concept of individualized medicine, which is known as the Chinese constitutional theory, proposed in the 1970s （Wang, 2012）. According to this theory, the human population is divided into nine constitutions, including one balanced constitution （Normality） and eight unbalanced constitutions （Yang-deficient, Yin-deficient, Qi-deficient,

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Very recently,a novel coronavirus,2019-nCoV,emerged in Wuhan,China and then quickly spread worldwide,resulting in>17,388 confirmed cases and 361 deaths as of 3 February 2020,thus calling for the development of safe and effective therapeutics and prophylatics.1,2 Similar to severe acute respiratory syndrome(SARS)-CoV,2019-nCoV belongs to lineage B betacoronavirus,and it has the ability to utilize human angiotensin-converting enzyme 2(ACE2)as a receptor to infect human cells.

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response

The pandemic of coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has posed serious threats to global health and economy,thus calling for the development of safe and effective vaccines.The receptorbinding domain(RBD)in the spike protein of SARS-CoV-2 is responsible for its binding to angiotensin-converting enzyme 2(ACE2)receptor.It contains multiple dominant neutralizing epitopes and serves as an important antigen for the development of COVID-19 vaccines.Here,we showed that immunization of mice with a candidate subunit vaccine consisting of SARS-CoV-2 RBD and Fc fragment of human IgG,as an immunopotentiator,elicited high titer of RBD-specific antibodies with robust neutralizing activity against both pseudotyped and live SARS-CoV-2 infections.The mouse antisera could also effectively neutralize infection by pseudotyped SARS-CoV-2 with several natural mutations in RBD and the IgG extracted from the mouse antisera could also show neutralization against pseudotyped SARS-CoV and SARS-related coronavirus(SARSr-CoV).Vaccination of human ACE2 transgenic mice with RBD-Fc could effectively protect mice from the SARS-CoV-2 challenge.These results suggest that SARS-CoV-2 RBD-Fc has good potential to be further developed as an effective and broad-spectrum vaccine to prevent infection of the current SARS-CoV-2 and its mutants,as well as future emerging SARSr-CoVs and re-emerging SARS-CoV.

High Sensitive Ambipolar Response towards Oxidizing NO2 and Reducing NH3 Based on Bis（phthalocyaninato） Europium Semiconductors

High sensitive chemical sensors towards NO2 and NH3 based on the self-assembled nanostructures of the heteroleptic and homoleptic bis（phthalocyaninato） europium complexes with octanaphthoxy phthalocyaninato ligands named Eu（Pc）[Pc（ONh）8] （1） and Eu[Pc（ONh）8]2 （2） [Pc = unsubstituted phthalocyaninate; Pc（ONh）8 = 2,3,9,10,16,17,23,24-octanaphthoxy phthalocyaninate] have been developed. The good conductivity, high crystal- linity and large specific surface area for the self-assemblies of 1 render it excellent sensing property for either electron-accepting gas NO2 in 50--250 ppb range or electron-donating gas NH3 in 2.5--12.5 ppm range due to the optimized molecular packing in the uniform-sized nanopartieles depending on the effective intermolecular interaction between double-decker molecules, among the best results of phthalocyanine-based chemical sensors for detection of NO2 and NH3 at room temperature. Interestingly, self-assemblies of I exhibited n-type response to NO2 and p-type response to NH3, which is the first example of ambipolar charge-transporting gas sensors fabricated from single- component organic semiconductors. However, the self-assemblies of 2 with sixteen bulky naphtboxy groups at the periphery of two Pc rings only present an n-type response to strong oxidant gas NO2 in a relatively high concentration of 0.5 - 1.5 ppm, while are insensitive to weak reducing gas NH3 due to the existence of great steric hindrance from bulky naphthoxy groups and more traps and/or defects in self-assemblies.

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2

Dear Editor,The ongoing COVID-19 pandemic has resulted in over 25.0 million confirmed cases and over 840,000 deaths globally.As the third severe respiratory disease outbreak caused by the coronavirus,COVID-19 has led to much larger infected populations and coverage of geographic areas than SARS and MERS.Such high prevalence of infection has raised significant concerns about the emergence and spread of escape variants,which may evade human immunity and eventually render candidate vaccines and antibody-based therapeutics ineffective.Indeed,some naturally mutated SARS-CoV or MERS-CoV strains from the sequential outbreaks were reported to resist neutralization by the antibodies isolated during the first outbreak1,2.

Recent advances in“universal”influenza virus antibodies:the rise of a hidden trimeric interface in hemagglutinin globular head

Influenza causes seasonal outbreaks yearly and unpredictable pandemics with high morbidity and mortality rates.Despite significant efforts to address influenza,it remains a major threat to human public health.This issue is partially due to the lack of antiviral drugs with potent antiviral activity and broad reactivity against all influenza virus strains and the rapid emergence of drug-resistant variants.Moreover,designing a universal influenza vaccine that is sufficiently immunogenic to induce universal antibodies is difficult.Some novel epitopes hidden in the hemagglutinin(HA)trimeric interface have been discovered recently,and a number of antibodies targeting these epitopes have been found to be capable of neutralizing a broad range of influenza isolates.These findings may have important implications for the development of universal influenza vaccines and antiviral drugs.In this review,we focused on the antibodies targeting these newly discovered epitopes in the HA domain of the influenza virus to promote the development of universal anti-influenza antibodies or vaccines and extend the discovery to other viruses with similar conformational changes in envelope proteins.

A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants

The current COVID-19 pandemic has heavily burdened the global public health system and may keep simmering for years.The frequent emergence of immune escape variants have spurred the search for prophylactic vaccines and therapeutic antibodies that confer broad protection against SARS-CoV-2 variants.Here we show that the bivalency of an affinity maturated fully human singledomain antibody(n3113.1-Fc)exhibits exquisite neutralizing potency against SARS-CoV-2 pseudovirus,and confers effective prophylactic and therapeutic protection against authentic SARS-CoV-2 in the host cell receptor angiotensin-converting enzyme 2(ACE2)humanized mice.The crystal structure of n3113 in complex with the receptor-binding domain(RBD)of SARS-CoV-2,combined with the cryo-EM structures of n3113 and spike ecto-domain,reveals that n3113 binds to the side surface of up-state RBD with no competition with ACE2.The binding of n3113 to this novel epitope stabilizes spike in up-state conformations but inhibits SARS-CoV-2 S mediated membrane fusion,expanding our recognition of neutralization by antibodies against SARS-CoV-2.Binding assay and pseudovirus neutralization assay show no evasion of recently prevalent SARS-CoV-2 lineages,including Alpha(B.1.1.7),Beta(B.1.351),Gamma(P.1),and Delta(B.1.617.2)for n3113.1-Fc with Y58L mutation,demonstrating the potential of n3113.1-Fc(Y58L)as a promising candidate for clinical development to treat COVID-19.

Inhalable antibodies for the treatment of COVID-19

By the end of July 2022,the SARS-CoV-2 pandemic had caused more than 6 million deaths worldwide.This viral infection results in a series of atypical respiratory diseases termed COVID-19,from asymptomatic infection to severe symptoms such as acute respiratory distress syndrome and pulmonary fibrosis.Development of vaccines and therapeutic measures that mitigate the sufferings caused by the pandemic has been achieved in a short period of time.Only 1 year after the emergence of the pandemic,COVID-19 vaccines have been approved in several countries.

High-performance bulk heterojunction-based photocathode with facile architecture for photoelectrochemical water splitting

Organic semiconductors are promising candidates as photoactive layers for photoelectrodes used in photoelectrochemical(PEC)cells due to their excellent light absorption and efficient charge transport properties with the help of interfacial materials.However,the use of multilayers will make the charge transfer mechanism more complicated and decrease the PEC performance of the photoelectrode caused by the increased contact resistance.In this work,a PM6:Y6 bulk heterojunction(BHJ)-based photocathode is fabricated for efficient PEC hydrogen evolution reaction(HER)in an acidic aqueous solution.With RuO_(2)as an interfacial modification layer,the photocathode with a simple structure(fluorine-doped tin oxide(FTO)/PM6:Y6/RuO_(2))generates a maximum photocurrent density up to-15 m A/cm^(2)at 0 V vs.reference hydrogen electrode(RHE),outperforming all previously reported BHJ-based photocathodes in terms of PEC performance.The highest ratiometric power-saved efficiency of 3.7%is achieved at 0.4 V vs.RHE.

Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection

Advancements in high-throughput sequencing(HTS)of antibody repertoires(Ig-Seq)have unprecedentedly improved our ability to characterize the antibody repertoires on a large scale.However,currently,only a few studies explored the influence of chronic HIV-1 infection on human antibody repertoires and many of them reached contradictory conclusions,possibly limited by inadequate sequencing depth and throughput.To better understand how HIV-1 infection would impact humoral immune system,in this study,we systematically analyzed the differences between the IgM(HIV-IgM)and IgG(HIV-IgG)heavy chain repertoires of HIV-1 infected patients,as well as between antibody repertoires of HIV-1 patients and healthy donors(HH).Notably,the public unique clones accounted for only a negligible proportion between the HIV-IgM and HIV-IgG repertoires libraries,and the diversity of unique clones in HIV-IgG remarkably reduced.In aspect of somatic mutation rates of CDR1 and CDR2,the HIV-IgG repertoire was higher than HIV-IgM.Besides,the average length of CDR3 region in HIV-IgM was significant longer than that in the HH repertoire,presumably caused by the great number of novel VDJ rearrangement patterns,especially a massive use of IGHJ6.Moreover,some of the B cell clonotypes had numerous clones,and somatic variants were detected within the clonotype lineage in HIV-IgG,indicating HIV-1 neutralizing activities.The in-depth characterization of HIV-IgG and HIV-IgM repertoires enriches our knowledge in the profound effect of HIV-1 infection on human antibody repertoires and may have practical value for the discovery of therapeutic antibodies.

Association between IDEAL-IQ MRI fat fraction quantification and pelvic bone marrow reserve function in concurrent chemoradiotherapy for cervical cancer

Objective:To analyze the association between iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantification sequence(IDEAL-IQ)magnetic resonance imaging(MRI)of bone marrow fat fraction and bone marrow reserve function during concurrent chemoradiotherapy for cervical cancer.Methods:The study retrospectively analyzed twenty-six patients with stage IB1 to IVA cervical cancer treated between February 2020 and November 2020.All patients received concurrent chemoradiotherapy that included platinum alone or combined paclitaxel and platinum.Pelvic IDEAL-IQ MRI(plain and enhanced)was performed before and after treatment.Regions of interest,including the fifth lumbar vertebra,sacrum,ilium,ischium,and femoral neck,were manually delineated,and the bone marrow fat fraction was measured.Peripheral blood cell counts were recorded during treatment,and the relationship between the fat fraction values and changes in the blood cell counts was explored.Results:IDEAL-IQ MRI bone marrow fat fraction was associated with platelet nadir and platelet decline during treatment.The average pelvic bone marrow fat fraction before chemoradiotherapy was moderately negatively correlated with platelet count nadir during concurrent chemoradiotherapy(r=-0.450,P?0.021).The change in average pelvic bone marrow fat fraction through chemoradiotherapy was moderately positively correlated with the degree of thrombocytopenia(r=0.399,P=0.044).Conclusion:Bone marrow fat content quantified by IDEAL-IQ was associated with platelet count nadir and the degree of thrombocytopenia in patients with cervical cancer undergoing concurrent chemoradiotherapy.

Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants

Dear Editor,In recent months,additional Omicron variants of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),including the BA.5 sublineage BF.7 and BQ.1.1 and the BA.2 linage recombination XBB,XBB.1.5 and XBB.1.16,have emerged following the BA.2 and BA.5 subvariants.Remarkably,BQ.1.1 and XBB showed substantial neutralization escape as compared with the previous variants,and have gradually become the dominant variants worldwide.1 These facts emphasize the urgency of identifying highly conserved SARS-CoV-2 epitopes,which would be essential for the design of universal vaccines and broadly neutralizing antibodies.

Insights into biological therapeutic strategies for COVID-19

The worldwide pandemic of novel coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)that emerged in late December 2019 requires the urgent development of therapeutic options.So far,numerous studies have investigated and uncovered the underlying epidemiology and clinical characteristics of COVID-19 infections in order to develop effective drugs.Compared with antiviral small-molecule inhibitors,biotherapeutics have unique advantages such as fewer side effects by virtue of their high specificity,and thus can be rapidly developed for promising treatments of COVID-19.Here,we summarize potential biotherapeutics and their mechanisms of action,including convalescent plasma,therapeutic antibodies,peptides,engineered ACE2,interferons,cytokine inhibitors,and RNAi-based therapeutics,and discuss in depth the advancements and precautions for each type of biotherapeutics in the treatment of COVID-19.